BIOMAT Database Logo BIOMAT Database Logo

Adenosine deaminase and immune function. 1976

M B Van der Weyden, and W N Kelley

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine

Related Publications

M B Van der Weyden, and W N Kelley
Studies of the relationship between adenosine deaminase and immune function.
August 1977, Journal of immunology (Baltimore, Md. : 1950),
M B Van der Weyden, and W N Kelley
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
August 1983, The Journal of clinical investigation,
M B Van der Weyden, and W N Kelley
[Adenosine deaminase activity and immune dysfunction (author's transl)].
January 1981, Allergie und Immunologie,
M B Van der Weyden, and W N Kelley
Adenosine and adenosine deaminase.
January 1948, Texas reports on biology and medicine,
M B Van der Weyden, and W N Kelley
Immune function in mice exposed to the adenosine deaminase inhibitor 2'-deoxycoformycin during immune system development.
January 1987, Immunopharmacology and immunotoxicology,
M B Van der Weyden, and W N Kelley
Regulation and function of adenosine deaminase in mice.
January 1996, Progress in nucleic acid research and molecular biology,
M B Van der Weyden, and W N Kelley
Modulating effect of adenosine deaminase on function of adenosine A1 receptors.
February 2005, Acta pharmacologica Sinica,
M B Van der Weyden, and W N Kelley
[Adenosine deaminase].
May 1995, Nihon rinsho. Japanese journal of clinical medicine,
M B Van der Weyden, and W N Kelley
[Adenosine deaminase].
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
M B Van der Weyden, and W N Kelley
[Adenosine deaminase].
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!